pulseadmin
Pharma major Dr Reddy’s is expected to report double-digit growth in both bottomline and topline, led by stable sales in the US and growth in the organic business.
Net profit for the quarter is seen rising 10% year-on-year (YoY), according to an average estimate of four brokerages, while revenues…
GIPHY App Key not set. Please check settings